A Feasibility Trial on Intranasal Evaporative Cooling for Acute Migraine in an At-Home Setting
The RhinoChill® intranasal cooling treatment at home was found to be non-feasible due to pain and discomfort, resulting in a high drop-out rate. Additionally, it had only minor effects on migraine pain and symptoms. The findings of this study led to the cancellation of a planned full-scale RCT.
Authors
- Erling Tronvik (ORCID: https://orcid.org/0000-0001-6059-0151)
- Patrik Midlöv (ORCID: https://orcid.org/0000-0002-5871-8731)
- Ingunn Winnberg (ORCID: https://orcid.org/0000-0001-6383-5257)
- Moa Wolff (ORCID: https://orcid.org/0000-0002-0656-7628)
- Mohammad F Bakhsheshi
Institutions
- Malmö University (SE)
- Lund University (SE)
- Medicon Village (SE)
- St Olav's University Hospital (NO)
Publication Details
- Journal
- Cureus
- Published
- 2024-11-03
- DOI
- https://doi.org/10.7759/cureus.72911
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00